Market Closed -
Bombay S.E.
06:00:47 2024-05-14 am EDT
|
5-day change
|
1st Jan Change
|
41.73
INR
|
+4.35%
|
|
-1.74%
|
-26.90%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,555
|
1,545
|
667.7
|
2,671
|
1,877
|
1,503
|
Enterprise Value (EV)
1 |
5,625
|
6,436
|
5,049
|
7,251
|
6,505
|
8,284
|
P/E ratio
|
-0.78
x
|
2.99
x
|
-0.69
x
|
131
x
|
-7.03
x
|
-2.83
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.56
x
|
0.3
x
|
0.2
x
|
0.64
x
|
0.43
x
|
0.24
x
|
EV / Revenue
|
2.01
x
|
1.26
x
|
1.52
x
|
1.75
x
|
1.5
x
|
1.31
x
|
EV / EBITDA
|
-3.28
x
|
17.4
x
|
-9.1
x
|
26.9
x
|
-62.8
x
|
376
x
|
EV / FCF
|
-0.35
x
|
-5.87
x
|
4.06
x
|
-9.62
x
|
66.1
x
|
15.7
x
|
FCF Yield
|
-289%
|
-17%
|
24.6%
|
-10.4%
|
1.51%
|
6.36%
|
Price to Book
|
3.83
x
|
1.71
x
|
3.38
x
|
8.61
x
|
-103
x
|
-3.05
x
|
Nbr of stocks (in thousands)
|
67,173
|
67,173
|
67,173
|
67,366
|
67,173
|
67,173
|
Reference price
2 |
23.15
|
23.00
|
9.940
|
39.65
|
27.95
|
22.37
|
Announcement Date
|
9/17/18
|
9/5/19
|
9/6/20
|
9/7/21
|
9/5/22
|
9/1/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,792
|
5,109
|
3,313
|
4,151
|
4,337
|
6,314
|
EBITDA
1 |
-1,714
|
368.9
|
-554.7
|
269.6
|
-103.5
|
22.04
|
EBIT
1 |
-1,771
|
337.7
|
-586.3
|
241.1
|
-115.2
|
11
|
Operating Margin
|
-63.42%
|
6.61%
|
-17.69%
|
5.81%
|
-2.66%
|
0.17%
|
Earnings before Tax (EBT)
1 |
-2,002
|
731.4
|
-977.4
|
-87.79
|
-293.7
|
-553.4
|
Net income
1 |
-1,998
|
517.1
|
-961.6
|
20.4
|
-267
|
-531.1
|
Net margin
|
-71.58%
|
10.12%
|
-29.02%
|
0.49%
|
-6.16%
|
-8.41%
|
EPS
2 |
-29.75
|
7.698
|
-14.32
|
0.3037
|
-3.975
|
-7.906
|
Free Cash Flow
1 |
-16,281
|
-1,097
|
1,244
|
-754
|
98.44
|
526.8
|
FCF margin
|
-583.18%
|
-21.48%
|
37.55%
|
-18.16%
|
2.27%
|
8.34%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
2,390.58%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
9/17/18
|
9/5/19
|
9/6/20
|
9/7/21
|
9/5/22
|
9/1/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
4,069
|
4,891
|
4,382
|
4,580
|
4,627
|
6,781
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-2.374
x
|
13.26
x
|
-7.899
x
|
16.99
x
|
-44.69
x
|
307.7
x
|
Free Cash Flow
1 |
-16,281
|
-1,097
|
1,244
|
-754
|
98.4
|
527
|
ROE (net income / shareholders' equity)
|
-312%
|
117%
|
-215%
|
445%
|
162%
|
88.5%
|
ROA (Net income/ Total Assets)
|
-6.37%
|
1.32%
|
-2.51%
|
1.07%
|
-0.49%
|
0.05%
|
Assets
1 |
31,380
|
39,319
|
38,382
|
1,905
|
54,077
|
-1,147,071
|
Book Value Per Share
2 |
6.040
|
13.50
|
2.940
|
4.610
|
-0.2700
|
-7.340
|
Cash Flow per Share
2 |
16.20
|
4.660
|
3.520
|
4.920
|
3.230
|
6.880
|
Capex
1 |
3.17
|
10.1
|
8.7
|
2.09
|
4.43
|
9.98
|
Capex / Sales
|
0.11%
|
0.2%
|
0.26%
|
0.05%
|
0.1%
|
0.16%
|
Announcement Date
|
9/17/18
|
9/5/19
|
9/6/20
|
9/7/21
|
9/5/22
|
9/1/23
|
|
1st Jan change
|
Capi.
|
---|
| -26.90% | 32.16M | | +5.92% | 105B | | -4.43% | 64.68B | | +60.48% | 43.21B | | +16.73% | 39.33B | | +6.77% | 32.99B | | +12.31% | 20.09B | | +13.41% | 17.05B | | +25.44% | 15.96B | | +5.80% | 14.69B |
Other Commodity Chemicals
|